453
Views
6
CrossRef citations to date
0
Altmetric
Comment

What is the best therapy for Whipple’s disease? Our point of view

, &
Pages 465-466 | Received 03 Oct 2016, Accepted 17 Nov 2016, Published online: 07 Dec 2016
 

Abstract

Although Whipple’s disease (WD) has been treated with antibiotics since the early 50s, the best antibiotics and the duration of the therapy have not yet been established. We consider here the pro and cons of the two most commonly used therapies, ceftriaxone followed by trimethoprim–sulfamethoxazole (TMP–SMZ) and hydroxychloroquine in combination with doxycycline. The therapy based on ceftriaxone and TMP–SMZ is efficient in the vast majority of patients for the first few years. However, since reinfections or reactivations can occur, a life-long prophylaxis is necessary and doxycycline is nowadays the best option. We thus propose a therapy based on merging these to therapies together, ceftriaxone, and TMP–SMZ for the first year(s) and then life-long prophylaxis with doxycycline.

Acknowledgements

We are grateful to Susan West for reading and correcting the manuscript.

The corresponding author confirms that he listed everyone who contributed significantly to the work. All authors approved the final version of the manuscript.

This work received no funding.

Disclosure statement

The authors have no conflict of interest.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 336.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.